AVITA Medical to Host Investor Webinar Briefing
23 févr. 2024 09h01 HE
|
AVITA Medical
AVITA Medical to host investor webinar briefing on February 27, 2024, at 2:00 p.m. PST.
AVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
22 févr. 2024 16h01 HE
|
AVITA Medical
AVITA Medical reports fourth quarter and full-year 2023 financial results.
AVITA Medical to Announce Fourth Quarter and Full Year 2023 Financial Results
01 févr. 2024 16h10 HE
|
AVITA Medical
AVITA Medical to announce fourth quarter and full year 2023 financial results on February 22, 2024, at 1:30 p.m. Pacific Time.
AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific
10 janv. 2024 16h01 HE
|
AVITA Medical
AVITA Medical announced exclusive multi-year distribution agreement with Stedical Scientific, Inc. to commercialize PermeaDerm in the United States.
AVITA Medical Announces Preliminary 2023 Financial Highlights, Provides 2024 Financial Guidance and Business Update
10 janv. 2024 09h01 HE
|
AVITA Medical
AVITA Medical announced preliminary unaudited financial highlights for the fourth quarter 2023, 2024 financial guidance, and full enrollment of TONE.
AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
04 janv. 2024 09h00 HE
|
AVITA Medical
AVITA Medical to present at JP Morgan's Annual Healthcare Conference in San Francisco on Thursday, January 11, 2024.
AVITA Medical to Host Investor Webinar Briefing
04 déc. 2023 09h00 HE
|
AVITA Medical
AVITA Medical to host investor webinar briefing on December 5, 2023, at 2:00 p.m. PST. Register at https://rebrand.ly/Dec2023webinar
AVITA Medical to Present at the Piper Sandler 35th Annual Healthcare Conference
21 nov. 2023 16h15 HE
|
AVITA Medical
VALENCIA, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of...
AVITA Medical Updates Full Year 2023 Guidance
20 nov. 2023 16h15 HE
|
AVITA Medical
VALENCIA, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of...
AVITA Medical Reports Third Quarter Financial Results with 51% Revenue Growth over the Same Period the Prior Year
09 nov. 2023 16h01 HE
|
AVITA Medical
VALENCIA, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of...